Denmark's biotechnology industry.. The Wall Street Journal

First of all, does anyone have subscription to the Wall Street Journal? I saw the article today on the newspaper but got no access to the online version..


Anyways, the free preview link is here.

At this time the major US and UK based pharmaceutical companies are running on risks of patents getting expired and more threats from generic competetors. The biggies therefore are trying out reaching small companies, with strong R&D departments, for fresh products to keep their positions on the market.

Partnerships have been formed (please see the WSJ article), and Danish biotech companies are at the biggies' interests.

but WHY? According to the WSJ, Danish biotech companies have more resource and are more focused on specific areas (e.g. the CNS system treatments) than the ones in other European countries. Moreover, Denmark's concentration on development of the "Medicon Valley" has made more venture capitalists willing to invest in Denmark than anywhere else.



The stocks are continuetly going up as well.. hmm.. the Copenhagen Stock Exchange in this sector has gone up 80% last year(!!). Again, thanks to the prosperity of Medicon Valley.

Apparently Denmark looked very good in 2006, and will continue to grow in biotech industry in 2007.


(中文好像跟上面的英文內容有點不一樣)
華爾街日報說丹麥的生技產業前景一片看好。因為Medicon Valley的專心建設，丹麥在2006年已經表現出歐洲生技R&D龍頭之姿。美國和英國的大藥廠們現在面臨到專利快要過期和眾多競爭者的威脅，正在積極向外找尋小公司的研發中新藥，丹麥的小藥廠們剛好符合需求。Glaxo Smith Kline 和 Schering-Plough已經跟丹麥的公司談好合作關係。

哥本哈根的生技股票去年漲了80% (!!) 歐洲道瓊healthcare sector去年也漲了6.7% (all from the WSJ)，華爾街日報說今年仍然會是有聲有色，創業投資人也還是會把錢送去。(想投資嗎)

小公司跟大公司的合作模式其實差不多是這樣，小公司有新鮮健康的R&D大公司有市場通路，合作起來人人開心。


有誰有華爾街日報的subscription阿?



More about the Medicon Valley:

Biotech in Denmark: Medicon Valley's Critical Mass and Strong Pharma Presence Provide a Model for British Columbia's Biotech Sector

Medicon Valley Academic

Urban and Regional Innovation Reseach Unit